Q2 2021 Holdings
Filed 2021-08-13 | 113 holdings | $800.8M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Alnylam Pharmaceuticals Inc(ALNY) | COM | 02043Q107 | $285.4M | 1,683,362 | 35.6% |
| Celldex Therapeutics Inc New(CLDX) | COM NEW | 15117B202 | $130.7M | 3,908,947 | 16.3% |
| Axsome Therapeutics Inc(AXSM) | COM | 05464T104 | $109.0M | 1,616,497 | 13.6% |
| C4 Therapeutics Inc(CCCC) | COM STK | 12529R107 | $81.3M | 2,149,228 | 10.2% |
| Castle Biosciences Inc(CSTL) | COM | 14843C105 | $58.6M | 799,009 | 7.3% |
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $39.6M | 2,000,000 | 4.9% |
| Apyx Medical Corporation(APYX) | COM | 03837C106 | $35.0M | 3,391,279 | 4.4% |
| Arbutus Biopharma Corp(ABUS) | COM | 03879J100 | $18.1M | 5,978,355 | 2.3% |
| Argenx SE(ARGX) | SPONSORED ADR | 04016X101 | $9.6M | 31,752 | 1.2% |
| Cytomx Therapeutics Inc(CTMX) | COM | 23284F105 | $8.9M | 1,400,939 | 1.1% |
| Acutus MED Inc(AFIB) | COM | 005111109 | $7.7M | 451,834 | 1.0% |
| Avita Medical Inc(RCEL) | COM | 05380C102 | $5.7M | 280,000 | 0.7% |
| Cvrx Inc(CVRX) | COM | 126638105 | $4.2M | 150,000 | 0.5% |
| Aziyo Biologics Inc(ELUT) | COM CL A | 05479K106 | $1.2M | 125,000 | 0.1% |
| Rocket Pharmaceuticals Inc(RCKT) | COM | 77313F106 | $663.9K | 14,990,286 | 0.1% |
| Spdr S&P 500 ETF TR(SPY) | TR UNIT | 78462F103 | $426.5K | 996,255 | 0.1% |
| Dicerna Pharmaceuticals Inc(DRNAUSD) | COM | 253031108 | $280.7K | 7,521,859 | 0.0% |
| Vericel Corp(VCEL) | COM | 92346J108 | $237.2K | 4,517,570 | 0.0% |
| Mirati Therapeutics Inc(MRTXEUR) | COM | 60468T105 | $235.4K | 1,457,532 | 0.0% |
| Illumina Inc(ILMN) | COM | 452327109 | $228.5K | 482,791 | 0.0% |
| PTC Therapeutics Inc(PTCT) | COM | 69366J200 | $223.8K | 5,293,966 | 0.0% |
| Establishment Labs Hldgs Inc(ESTA) | COM | G31249108 | $202.6K | 2,319,138 | 0.0% |
| Masimo Corp(MASI) | COM | 574795100 | $200.3K | 826,210 | 0.0% |
| Natera Inc(NTRA) | COM | 632307104 | $194.4K | 1,712,234 | 0.0% |
| Protagonist Therapeutics Inc(PTGX) | COM | 74366E102 | $157.4K | 3,507,390 | 0.0% |
| 10X Genomics Inc(TXG) | CL A COM | 88025U109 | $143.8K | 734,481 | 0.0% |
| Dermtech Inc(DMTKQ) | COM | 24984K105 | $129.6K | 3,118,665 | 0.0% |
| Globus MED Inc(GMED) | CL A | 379577208 | $129.5K | 1,670,811 | 0.0% |
| Axonics Inc(AXNX*) | COM | 05465P101 | $123.3K | 1,943,864 | 0.0% |
| Stoke Therapeutics Inc(STOK) | COM | 86150R107 | $122.7K | 3,644,248 | 0.0% |
| Guardant Health Inc(GH) | COM | 40131M109 | $114.0K | 918,253 | 0.0% |
| Quidel Corp | COM | 74838J101 | $112.6K | 878,533 | 0.0% |
| Tandem Diabetes Care Inc(TNDM) | COM NEW | 875372203 | $111.8K | 1,147,408 | 0.0% |
| Avidity Biosciences Inc(RNA) | COM | 05370A108 | $98.7K | 3,995,000 | 0.0% |
| Essa Pharma Inc(EPIEUR) | COM NEW | 29668H708 | $87.3K | 3,053,919 | 0.0% |
| Prometheus Biosciences Inc | COM | 74349U108 | $76.0K | 3,264,031 | 0.0% |
| Ideaya Biosciences Inc(IDYA) | COM | 45166A102 | $68.6K | 3,266,255 | 0.0% |
| Macrogenics Inc(MGNX) | COM | 556099109 | $68.4K | 2,546,925 | 0.0% |
| Regenxbio Inc(RGNX) | COM | 75901B107 | $68.3K | 1,757,743 | 0.0% |
| Agenus Inc(AGENEUR) | COM NEW | 00847G705 | $62.8K | 11,437,238 | 0.0% |
| Tarsus Pharmaceuticals Inc(TARS) | COM | 87650L103 | $58.4K | 2,013,601 | 0.0% |
| Nanostring Technologies Inc(NSTGEUR) | COM | 63009R109 | $52.1K | 804,029 | 0.0% |
| Pulmonx Corp(LUNG) | COM | 745848101 | $49.8K | 1,129,600 | 0.0% |
| Relmada Therapeutics Inc(RLMD) | COM | 75955J402 | $49.2K | 1,538,026 | 0.0% |
| Landos Biopharma Inc | COM | 515069102 | $48.5K | 4,275,722 | 0.0% |
| Immunocore Hldgs PLC(IMCR) | ADS | 45258D105 | $47.9K | 1,245,532 | 0.0% |
| Iteos Therapeutics Inc(5E7) | COM | 46565G104 | $44.0K | 1,716,585 | 0.0% |
| Proqr Thrapeutics N V | SHS EURO | N71542109 | $43.4K | 6,443,113 | 0.0% |
| Olink Hldg AB | SPONSORED ADS | 680710100 | $43.0K | 1,248,188 | 0.0% |
| GH Research PLC(GHRS) | ORDINARY SHARES | G3855L106 | $42.7K | 2,168,957 | 0.0% |